T cell lineage maturation is a highly regulated process requiring intact DNA repair capacity 1,2. BRCA1 (breast cancer 1, early onset) is a tumor suppressor that probably has a DNA repair function.
Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune ...
The firms partnered earlier this year to leverage each other's technologies and develop multiple T-cell receptor-guided T-cell engagers.
Roche RHHBY announced that it will acquire clinical-stage biopharmaceutical company Poseida Therapeutics, Inc. PSTX for $9 ...
SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited to share ...